(Q46306865)

21 December 2017

title

The HVTN 503/Phambili study: efficacy is always the issue (English)

1 reference

21 December 2017

author name string

Zaneeta Dhesi

series ordinal

1

1 reference

21 December 2017

Justin Stebbing

series ordinal

2

1 reference

21 December 2017

publication date

11 May 2011

1 reference

21 December 2017

Lancet Infectious Diseases

published in

1 reference

21 December 2017

volume

11

1 reference

21 December 2017

issue

7

1 reference

21 December 2017

page(s)

490-491

1 reference

21 December 2017

Origins of HIV and the evolution of resistance to AIDS.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970103-7

7 January 2021

Safety and efficacy of the HVTN 503/Phambili study of a clade-B-based HIV-1 vaccine in South Africa: a double-blind, randomised, placebo-controlled test-of-concept phase 2b study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970103-7

7 January 2021

Replication-defective adenovirus serotype 5 vectors elicit durable cellular and humoral immune responses in nonhuman primates

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970103-7

7 January 2021

Safety and Immunogenicity of a Replication‐Incompetent Adenovirus Type 5 HIV‐1 Clade Bgag/pol/nefVaccine in Healthy Adults

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970103-7

7 January 2021

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970103-7

7 January 2021

A tail of Tetherin: how pandemic HIV-1 conquered the world.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970103-7

7 January 2021

Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970103-7

7 January 2021

HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970103-7

7 January 2021

The impact of incident and prevalent herpes simplex virus-2 infection on the incidence of HIV-1 infection among commercial sex workers in South Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970103-7

7 January 2021

PRO2000 vaginal gel for prevention of HIV-1 infection (Microbicides Development Programme 301): a phase 3, randomised, double-blind, parallel-group trial

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970103-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS1473-3099%2811%2970103-7

1 reference

7 January 2021

10.1016/S1473-3099(11)70103-7

Identifiers

DOI

1 reference

21 December 2017

1 reference

21 December 2017